Integer (NYSE:ITGR) Given Buy Rating at Benchmark

Integer (NYSE:ITGR)‘s stock had its “buy” rating reaffirmed by equities researchers at Benchmark in a report released on Wednesday, Benzinga reports. They currently have a $130.00 price target on the medical equipment provider’s stock. Benchmark’s price objective points to a potential upside of 2.23% from the company’s previous close.

A number of other research analysts also recently weighed in on ITGR. Truist Financial increased their price objective on shares of Integer from $137.00 to $145.00 and gave the company a “buy” rating in a research report on Tuesday. Oppenheimer assumed coverage on Integer in a research report on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 target price on the stock. Bank of America upped their price target on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research report on Tuesday. Finally, Citigroup boosted their price objective on shares of Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research report on Tuesday. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $137.29.

Integer Stock Down 0.0 %

Integer stock traded down $0.02 during trading hours on Wednesday, hitting $127.17. The stock had a trading volume of 5,223 shares, compared to its average volume of 315,817. The stock’s 50-day moving average price is $123.37 and its 200-day moving average price is $119.31. Integer has a 12-month low of $69.40 and a 12-month high of $131.87. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $4.26 billion, a P/E ratio of 44.03, a price-to-earnings-growth ratio of 1.87 and a beta of 1.09.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, beating the consensus estimate of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The business had revenue of $436.20 million for the quarter, compared to the consensus estimate of $437.00 million. During the same period last year, the business posted $1.14 EPS. The company’s revenue was up 9.0% compared to the same quarter last year. Equities research analysts anticipate that Integer will post 5.31 EPS for the current fiscal year.

Insider Activity at Integer

In other news, Director Jean M. Hobby sold 11,960 shares of the business’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the transaction, the director now owns 2,280 shares of the company’s stock, valued at $272,824.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 2.00% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Integer

Hedge funds have recently made changes to their positions in the company. Xponance Inc. raised its stake in Integer by 4.9% during the second quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider’s stock valued at $245,000 after purchasing an additional 99 shares in the last quarter. GAMMA Investing LLC raised its position in shares of Integer by 60.9% during the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after buying an additional 142 shares in the last quarter. Envestnet Portfolio Solutions Inc. increased its stake in Integer by 3.6% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider’s stock worth $689,000 after acquiring an additional 205 shares during the last quarter. Arizona State Retirement System lifted its stake in shares of Integer by 2.4% in the 2nd quarter. Arizona State Retirement System now owns 9,378 shares of the medical equipment provider’s stock valued at $1,086,000 after purchasing an additional 219 shares during the last quarter. Finally, Guidance Capital Inc. boosted its holdings in shares of Integer by 7.4% in the 2nd quarter. Guidance Capital Inc. now owns 4,527 shares of the medical equipment provider’s stock worth $538,000 after purchasing an additional 310 shares during the period. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.